Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 2 Tumor-Agnostic 1

Conditions

Carcinoma, Squamous Cell 1 Carcinoma 1

Interventions

Paclitaxel 9 Carboplatin 9 pembrolizumab 7 Radiotherapy 7 Cisplatin 5 Axitinib 4 Pemetrexed 3 Nivolumab 3 trifluridine tipiracil drug combination 2 regorafenib 2 osimertinib 2 fludarabine 2 dacomitinib 2 catumaxomab 2 Trastuzumab 2 Sunitinib 2 Radiotherapy, Intensity-Modulated 2 Nurses 2 Interleukin-2 2 Gemcitabine 2 Docetaxel 2 Cyclophosphamide 2 Cetuximab 2 Bevacizumab 2 Albumin-Bound Paclitaxel 2 130-nm albumin-bound paclitaxel 2 vatalanib 1 temsirolimus 1 sovateltide 1 selinexor 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Carcinoma × selinexor × Tumor-Agnostic × Clear all

NCT02213133 2023-01-26

STARRS

Karyopharm Therapeutics Inc

Phase 2 Terminated

45 enrolled 12 charts

Carcinoma, Carcinoma, Squamous Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡